Neville F. Hacker

ORCID: 0000-0002-1445-2302 · 13 papers in corpus
observational 2026
JAMA network open ·doi:10.1001/jamanetworkopen.2026.1332

IMPORTANCE: High-quality evidence on cancer occurrence for women who have used medically assisted reproduction (MAR) is required to guide care. OBJECTIVE: To compare cancer incidence in MAR-exposed women with the general population of wome…

observational 2026
JAMA network open ·doi:10.1001/jamanetworkopen.2026.22832

IMPORTANCE: It is critical that women undertaking medically assisted reproductive (MAR) treatment and their clinicians know whether the treatments are associated with an increased risk of hormone-related cancers. OBJECTIVE: To determine th…

other 2019
Nature communications ·doi:10.1038/s41467-019-11862-x

Mucinous ovarian carcinoma (MOC) is a unique subtype of ovarian cancer with an uncertain etiology, including whether it genuinely arises at the ovary or is metastatic disease from other organs. In addition, the molecular drivers of invasive…

observational 2017
Translational oncology ·doi:10.1016/j.tranon.2017.01.014

OBJECTIVE: The ROR1 and ROR2 receptor tyrosine kinases have both been implicated in ovarian cancer progression and have been shown to drive migration and invasion. There is an increasing importance of the role of stroma in ovarian cancer me…

review 2014
International journal of molecular medicine ·doi:10.3892/ijmm.2014.1659

Vulvar melanoma is the second most common vulvar cancer. Patients with vulvar melanoma usually present with the disease at a late stage and have a poor prognosis. The prognostic predictors reported in the literature are not unequivocal and …

other 2012
PloS one ·doi:10.1371/journal.pone.0031885

BACKGROUND: Activation of the Wnt signaling pathway is implicated in aberrant cellular proliferation in various cancers. In 40% of endometrioid ovarian cancers, constitutive activation of the pathway is due to oncogenic mutations in β-caten…

diagnostic-accuracy 2011
Gynecologic Oncology ·doi:10.1016/j.ygyno.2011.02.022

OBJECTIVE: About 70% of epithelial ovarian cancer patients (EOC) are diagnosed at advanced stage with a five-year survival rate of only 30%. Whilst CA125 detects peritoneally-spread disease, it has limited sensitivity for early cancers, man…

observational 2006
Gynecologic Oncology ·doi:10.1016/j.ygyno.2006.08.026

OBJECTIVE: The purpose of this study was to define the incidence of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients with clear cell carcinoma (CCC) of the ovary and to investigate the prognostic factors in such patients…

2004

Early detection remains the most promising approach to improve long-term survival of patients with ovarian cancer. In a five-center case-control study, serum proteomic expressions were analyzed on 153 patients with invasive epithelial ovari…

observational 1999
British journal of cancer ·doi:10.1038/sj.bjc.6690731

It has been suggested that oestrogen replacement therapy is associated with risk of epithelial ovarian cancer of the endometrioid type. Using data from an Australian population-based case-control study, the relation between unopposed oestro…

review 1988
Obstetrics and gynecology

Malignant transformation of endometriosis is a well documented phenomenon. Although it occurs most commonly in the ovaries, there have been approximately 50 reported cases of extraovarian malignant transformation of endometriosis. This pape…

1986
·doi:10.3109/01674828609016764

In endometrial cancer, early detection is usually facilitated by the onset of abnormal bleeding: Despite this, patients at times evidence considerable delay between onset of abnormal bleeding and seeking medical care. The current study of 3…

other 1983
Obstetrics & Gynecology

Fifteen pelvic exenteration patients from 2 institutions participated in semistructured interviews and objective assessment to examine postoperative psychologic, social, and sexual functioning. Analyses of variance indicated significant dif…